The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Genetic Testing for All Breast Cancer Patients (GET FACTS)
Official Title: Genetic Testing for All Breast Cancer Patients (GET FACTS)
Study ID: NCT04245176
Brief Summary: This study is designed to determine the impact of a novel genetic counseling method on surgical decisions in individuals with newly diagnosed breast cancer This research study involves an expedited and surgery-specific form of genetic counseling. The names of the study methods involved in this trial are/is: * Quantitative genetic counseling (discussion is guided by tables and graphs) * Standard genetic counseling
Detailed Description: * The research study procedures include screening for eligibility and study interventions including evaluations and follow up visits * After receiving genetic testing, participants will be placed into one of two counseling methodology groups: * Standard genetic counseling: Standard of care discussion * Quantitative genetic counseling: Discussion is guided by tables and graphs. * Participants will be on the research study for up to six months, with an optional extension to two years. * It is expected that about 450 people will participate. * This research study is a Feasibility Study, which is the first-time investigators are examining this form of genetic counseling. * This is a randomized study. Randomization means being put into a group by chance. It is like flipping a coin. Neither the participant nor the Investigator will choose the group the participant is assigned to.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Name: Tara King, MD
Affiliation: Dana-Farber Cancer Institute
Role: PRINCIPAL_INVESTIGATOR